Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
Clinical trial NCT02951052 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02951052
- Sponsor
- ViiV Healthcare
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-28
- Primary completion
- 2018-05-29
- Enrollment
- 618
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.